PHARMADIRECT A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMADIRECT A/S
PHARMADIRECT A/S (CVR number: 34221138) is a company from KØGE. The company recorded a gross profit of -10 kDKK in 2022. The operating profit was -10 kDKK, while net earnings were -29 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.4 %, which can be considered poor and Return on Equity (ROE) was -1.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 99.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. PHARMADIRECT A/S's liquidity measured by quick ratio was 141.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -6.45 | -5.71 | -7.33 | -6.50 | -10.00 |
EBIT | -6.45 | -5.71 | -7.33 | -6.50 | -10.00 |
Net earnings | -21.36 | -20.51 | -22.92 | -27.43 | -29.03 |
Shareholders equity total | 2 509.98 | 2 489.47 | 2 466.55 | 2 439.11 | 2 410.08 |
Balance sheet total (assets) | 2 516.23 | 2 495.27 | 2 472.34 | 2 446.29 | 2 427.26 |
Net debt | -2 513.44 | -2 495.27 | -2 472.34 | -2 446.29 | -2 420.88 |
Profitability | |||||
EBIT-% | |||||
ROA | -0.3 % | -0.2 % | -0.3 % | -0.3 % | -0.4 % |
ROE | -0.8 % | -0.8 % | -0.9 % | -1.1 % | -1.2 % |
ROI | -0.3 % | -0.2 % | -0.3 % | -0.3 % | -0.4 % |
Economic value added (EVA) | -6.34 | -5.54 | -7.04 | -6.21 | -9.64 |
Solvency | |||||
Equity ratio | 99.8 % | 99.8 % | 99.8 % | 99.7 % | 99.3 % |
Gearing | 0.3 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 402.1 | 430.2 | 426.3 | 340.9 | 141.3 |
Current ratio | 402.1 | 430.2 | 426.3 | 340.9 | 141.3 |
Cash and cash equivalents | 2 513.44 | 2 495.27 | 2 472.34 | 2 446.29 | 2 427.26 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | B | B | B | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.